Search research articles
Contact Us
Filters
Showing results (31-40 of 75) with videos related to
Page
of 8
Sort By:
The Oncologist
|
August 22, 2012
Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)
Patricia Pautier, Anne Floquet, Nicolas Penel, et al.
Oncotarget
|
October 27, 2015
Prostaglandins induce early growth response 1 transcription factor mediated microsomal prostaglandin E2 synthase up-regulation for colorectal cancer progression
Konstantinos Stamatakis, Marta Jimenez-Martinez, Alba Jimenez-Segovia, et al.
JMIR Human Factors
|
April 30, 2025
Immersive Virtual Reality eHealth Intervention to Reduce Anxiety and Depression in Pregnant Women: Randomized Controlled Trial
Marta Jimenez-Barragan, Amparo Del Pino Gutierrez, Gloria Sauch Valmaña, et al.
Oncotarget
|
November 16, 2017
Longitudinal serum metabolomics evaluation of trastuzumab and everolimus combination as pre-operative treatment for HER-2 positive breast cancer patients
Elodie Jobard, Olivier Trédan, Thomas Bachelot, et al.
Plos One
|
March 19, 2021
Reliability and validity study of the Spanish adaptation of the "Wijma Delivery Expectancy/Experience Questionnaire" (W-DEQ-A)
Celia Maria Ortega-Cejas, Juan Roldán-Merino, Teresa Lluch-Canut, et al.
Medicina Clinica
|
January 18, 2022
Value of advanced interatrial block in the diagnosis of the ischemic stroke's aetiology: A cohort study
Jose Maria Vieitez Florez, Arantxa Sánchez Sánchez, Rafael Martínez Moya, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
September 19, 2021
Emergency severity level-3 patient flow based on point-of-care testing improves patient outcomes
Marta Jimenez-Barragan, Manuel Rodriguez-Oliva, Catalina Sanchez-Mora, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 27, 2021
Rucaparib in patients presenting a metastatic breast cancer with homologous recombination deficiency, without germline BRCA1/2 mutation
Anne Patsouris, Kadija Diop, Olivier Tredan, et al.
The Lancet. Oncology
|
November 6, 2012
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
Thomas Bachelot, Gilles Romieu, Mario Campone, et al.
Journal for Immunotherapy of Cancer
|
January 8, 2025
Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for recurrent advanced cervical cancer: an open-label phase I/II study
Jean-Sébastien Frenel, Laurent Mathiot, Claire Cropet, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 75) with videos related to
Sort By:
Page
of 8
The Oncologist
|
August 22, 2012
Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)
Patricia Pautier, Anne Floquet, Nicolas Penel, et al.
Oncotarget
|
October 27, 2015
Prostaglandins induce early growth response 1 transcription factor mediated microsomal prostaglandin E2 synthase up-regulation for colorectal cancer progression
Konstantinos Stamatakis, Marta Jimenez-Martinez, Alba Jimenez-Segovia, et al.
JMIR Human Factors
|
April 30, 2025
Immersive Virtual Reality eHealth Intervention to Reduce Anxiety and Depression in Pregnant Women: Randomized Controlled Trial
Marta Jimenez-Barragan, Amparo Del Pino Gutierrez, Gloria Sauch Valmaña, et al.
Oncotarget
|
November 16, 2017
Longitudinal serum metabolomics evaluation of trastuzumab and everolimus combination as pre-operative treatment for HER-2 positive breast cancer patients
Elodie Jobard, Olivier Trédan, Thomas Bachelot, et al.
Plos One
|
March 19, 2021
Reliability and validity study of the Spanish adaptation of the "Wijma Delivery Expectancy/Experience Questionnaire" (W-DEQ-A)
Celia Maria Ortega-Cejas, Juan Roldán-Merino, Teresa Lluch-Canut, et al.
Medicina Clinica
|
January 18, 2022
Value of advanced interatrial block in the diagnosis of the ischemic stroke's aetiology: A cohort study
Jose Maria Vieitez Florez, Arantxa Sánchez Sánchez, Rafael Martínez Moya, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
September 19, 2021
Emergency severity level-3 patient flow based on point-of-care testing improves patient outcomes
Marta Jimenez-Barragan, Manuel Rodriguez-Oliva, Catalina Sanchez-Mora, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 27, 2021
Rucaparib in patients presenting a metastatic breast cancer with homologous recombination deficiency, without germline BRCA1/2 mutation
Anne Patsouris, Kadija Diop, Olivier Tredan, et al.
The Lancet. Oncology
|
November 6, 2012
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
Thomas Bachelot, Gilles Romieu, Mario Campone, et al.
Journal for Immunotherapy of Cancer
|
January 8, 2025
Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for recurrent advanced cervical cancer: an open-label phase I/II study
Jean-Sébastien Frenel, Laurent Mathiot, Claire Cropet, et al.
Page
of 8